Polaryx Therapeutics, Inc. (PLYX)
2.09
-0.05
(-2.34%)
USD |
NASDAQ |
Sep 25, 16:00
Polaryx Therapeutics Net Income (Quarterly) : -1.38M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.38M |
| March 31, 2026 | -2.544M |
| December 31, 2025 | -1.495M |
| September 30, 2025 | -1.43M |
| June 30, 2025 | -1.008M |
| Date | Value |
|---|---|
| March 31, 2025 | -5.052M |
| December 31, 2024 | -0.723M |
| September 30, 2024 | -0.771M |
| June 30, 2024 | -1.252M |
| March 31, 2024 | -27.61M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.164M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 169.40M |
| Fulcrum Therapeutics, Inc. | -26.18M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.38M |
| EPS Diluted (Quarterly) | -0.0286 |
| Enterprise Value | 92.64M |
| Earnings Yield | -6.90% |
| Normalized Earnings Yield | -5.751 |